[[4-[2-[[(3-Ethyl-2,5-dihydro-4-methyl-2-oxo-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]-carbamic acid ethyl ester

We are [[4-[2-[[(3-Ethyl-2,5-dihydro-4-methyl-2-oxo-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]-carbamic acid ethyl ester CAS:318515-70-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:[[4-[2-[[(3-Ethyl-2,5-dihydro-4-methyl-2-oxo-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]-carbamic acid ethyl ester
CAS.NO:318515-70-7
Synonyms:[[4-[2-[[(3-Ethyl-2,5-dihydro-4-methyl-2-oxo-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]-carbamic acid ethyl ester
4-[2-[(3-Ethyl-4-methyl-2-oxo-3-pyrrolin-1-yl)carboxamido]ethyl]phenyl]sulfonyl]carbamic Acid Ethyl Ester
N-[[4-[2-[[(3-Ethyl-2,5-dihydro-4-methyl-2-oxo-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]carbamic Acid Ethyl Ester
N-[4-[2-(3-ETHYL-4-METHYL-2-OXO-3-PYRROLINE-1-CARBOXAMIDO)ETHYL]BENZENESULFONAMIDE
3-ETHYL-4-METHYL-2-OXO-N-(4-SULFAMOYLPHENETHYL)-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE
{{4-{2-{[(3-Ethyl-2,5-dihydro-4-methyl-2-oxo-1H-pyrol-1-yl)carbonyl]amino}ethyl}phenyl}sulphonyl}carbamic acid
 
Physical and Chemical Properties:
Density 1.293
Molecular Formula C19H25N3O6S
Molecular Weight 423.48300
Index of Refraction 1.563
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Glimepiride(CAS:93479-97-1).

[[4-[2-[[(3-Ethyl-2,5-dihydro-4-methyl-2-oxo-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]-carbamic acid ethyl ester


Related News: By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant’s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed.Ethyl 2-(triphenylphosphoranylidene)propionate CAS:5717-37-3 By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant’s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed.3-Cyanobenzylchloride Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.Methyl 2-cyclohexyl-2-hydroxy-2-phenylacetate Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.

Related Products
Product Name
(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid View Details
2-chloro-N-methyl-3-oxobutanamide View Details
Glycine ethyl ester hydrochloride View Details
3-Bromo-1H-pyrazolo[3,4-d]pyrimidin-4-amine manufacturer 5-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)benzylidene)thiazolidine-2,4-dione manufacturer 1-(Chloro-1-Pyrrolidinylmethylene)Pyrrolidinium Tetrafluoroborate manufacturer Ethanethioic acid S-ethyl ester manufacturer N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-5-hydroxy-L-tryptophan manufacturer